Navco Pharmaceuticals (TSXV:NAV) FCF Margin % : 0.00% (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Navco Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2023 was C$0.00 Mil. Navco Pharmaceuticals's Revenue for the three months ended in Mar. 2023 was C$0.00 Mil. Therefore, Navco Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2023 was 0.00%.

As of today, Navco Pharmaceuticals's current FCF Yield % is -1.90%.

The historical rank and industry rank for Navco Pharmaceuticals's FCF Margin % or its related term are showing as below:

TSXV:NAV's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -0.03
* Ranked among companies with meaningful FCF Margin % only.

Navco Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Navco Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals FCF Margin % Chart

Navco Pharmaceuticals Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

FCF Margin %

Navco Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
FCF Margin %	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of Navco Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Navco Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navco Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Navco Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Navco Pharmaceuticals's FCF Margin % falls into.

Navco Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Navco Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2021 )	/	Revenue (A: Jun. 2021 )
	=	-0.081	/	0
	=	%

Navco Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	0	/	0
	=	%

Navco Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Navco Pharmaceuticals (TSXV:NAV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.